Who Should Pay for Global Health, and How Much?

Carrasco, Luis R and Coker, Richard and Cook, Alex R (2013): Who Should Pay for Global Health, and How Much? Published in: Who Should Pay for Global Health, and How Much? , Vol. 10, No. 2 (19 February 2013)

Abstract

Roman Carrasco and colleagues propose a "cap and trade" system for global health involving a cost-effectiveness criterion and a DALY global credit market, mirroring global carbon emission permits trading markets to mitigate climate change.

• Item Type: MPRA Paper
• Language: English
• Keywords: Global Health, Health economics
• Subjects: I - Health, Education, and Welfare > I1 - Health > I10 - General; I - Health, Education, and Welfare > I1 - Health > I14 - Health and Inequality; I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health

References

Fidler DP (1996) Globalization, international law, and emerging infectious diseases. Emerg Infect Dis 2: 77.

Gould EA, Gallian P, De Lamballerie X, Charrel RN (2010) First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clin Microbiol Infec 16: 1702– 1704.

Gascon J, Bern C, Pinazo MJ (2010) Chagas disease in Spain, the United States and other nonendemic countries. Acta Tropica 115: 22–27.

Chen LC, Evans TG, Cash RA (1999) Health as a global public good. Kaul I, Grunberg I, Stern M, editors. Global public goods: international cooperation in the 21st century. New York: Oxford University Press.

Kassalow JS, Fund MM (2001) Why health is important to US foreign policy. New York: Council on Foreign Relations.

Sachs JD, McArthur JW (2005) The millennium project: a plan for meeting the millennium development goals. Lancet 365: 347–353.

Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al. (2006) Disease control priorities in developing countries. New York: Oxford University Press.

Tan-Torres Edejer T, Aikins M, Black R, Wolfson L, Hutubessy R, et al. (2005) Cost effectiveness analysis of strategies for child health in developing countries. BMJ 331: 1177.

Morel CM, Lauer JA, Evans DB (2005) Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ 331: 1299.

Goodman CA, Coleman PG, Mills AJ (1999) Cost-effectiveness of malaria control in sub- Saharan Africa. Lancet 354: 378–385.

High-Level Taskforce on International Innovative Financing for Health Systems (2009) Working Group 1 technical report: constraints to scaling up and costs. Available: http://www.who.int/ pmnch/media/membernews/2009/20090313_ hltfmeeting/en/index.html. Accessed 18 January 2013.

Leach-Kemon K, Chou DP, Schneider MT, Tardif A, Dieleman JL, et al. (2012) The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries. Health Affair 31: 228–235.

Hardin G (1968) The tragedy of the commons. Science 162: 1243–1248.

Ostrom E, Burger J, Field CB, Norgaard RB, Policansky D (1999) Revisiting the commons: local lessons, global challenges. Science 284: 278– 282.

Dietz T, Ostrom E, Stern PC (2003) The struggle to govern the commons. Science 302: 1907–1912.

World Health Organization (2008) The global burden of disease 2004 update. Geneva: World Health Organization.

Murray CJL (1994) Quantifying the burden of disease - the technical basis for disability-adjusted life years. B World Health Organ 72: 429–445.

Edejer TTT, Baltussen R, Adam T, Hutubessy R, Acharya A (2003) WHO guide to cost-effectiveness analysis. Geneva: World Health Organization.

Sachs JD (2001) Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. World Health Organization, Geneva, Switzerland, 2001. Available: http://whqlibdoc. who.int/publications/2001/924154550X.pdf. Accessed 4 November 2011.

SIPRI (2011) SIPRI military expenditure database. Stockholm International Peace Research Institute. Accessed 18 January 2013. Available: http://www.sipri.org/.

Nolte E, McKee M (2004) Measuring the health of nations: analysis of mortality amenable to health care. J Epidemiol Community H 58: 326– 326.

Ooms G, Stuckler D, Basu S, McKee M (2010) Financing the Millennium Development Goals for health and beyond: sustaining the ‘‘Big Push’’. Global Health 6: 17.

Piva P, Dodd R (2009) Where did all the aid go? An in-depth analysis of increased health aid flows over the past 10 years. B World Health Organ 87: 930–939.

Fidler DP (2007) Reflections on the revolution in health and foreign policy. B World Health Organ 85: 243–244.

WHO (2010) CHOosing Interventions that are Cost Effective (WHO-CHOICE). Accessed 18 January 2013. Available: http://www.who.int/ choice/costs/prog_costs/en/index.html.

Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, et al. (2006) Advancement of global health: key messages from the Disease Control Priorities Project. Lancet 367: 1193– 1208.

Oppenheimer M, Petsonk A (2005) Article 2 of the UNFCCC: historical origins, recent interpretations. Climatic Change 73: 195–226.

Klepper G (2011) The future of the European Emission Trading System and the Clean Development Mechanism in a post-Kyoto world. Energ Econ 33: 687–698.

Kossoy A, Ambrosi P (2010) State and trends of the carbon market. Washington (D.C.): World Bank.

Hull B, Dey A, Mahajan D, Menzies R, McIntyre PB (2011) Immunisation coverage annual report, 2009. Commun Dis Intell 35: 132–148.

Butler JRG, McIntyre P, Raina MacIntyre C, Gilmour R, Howarth AL, et al. (2004) The costeffectiveness of pneumococcal conjugate vaccination in Australia. Vaccine 22: 1138–1149.

Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, et al. (2010) Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 376: 1775–1784.

Atun R, Knaul FM, Akachi Y, Frenk J (2012) Innovative financing for health: what is truly innovative? Lancet 380: 2044–2049.